Language
English
Publication Date
12-12-2023
Journal
Journal of the American College of Cardiology
DOI
10.1016/j.jacc.2023.10.020
PMID
38057067
Keywords
Humans, RNA, Small Interfering, Hypercholesterolemia, Treatment Outcome, Proprotein Convertase 9, Anticholesteremic Agents
Published Open-Access
yes
Recommended Citation
Christie M Ballantyne, Abdul Mannan Khan Minhas, and Carl E Orringer, "Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?" (2023). Faculty, Staff and Students Publications. 6674.
https://digitalcommons.library.tmc.edu/baylor_docs/6674